Publicaciones
El conocimiento generado en IrsiCaixa se comparte con la comunidad científica a través de la publicación de artículos en revistas científicas de alto impacto.
An anti-SARS-CoV-2 metabolite is reduced in diabetes.
Heterogeneous Infectivity and Pathogenesis of SARS-CoV-2 Variants Beta, Delta and Omicron in Transgenic K18-hACE2 and Wildtype Mice.
Unraveling the antiviral activity of plitidepsin by subcellular and morphological analysis.
Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19.
Performance of SARS-CoV-2 Antigen-Detecting Rapid Diagnostic Tests for Omicron and Other Variants of Concern.
Clinical course impacts early kinetics,magnitude, and amplitude of SARS-CoV-2 neutralizing antibodies beyond 1 year after infection.
Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies.
HIV-1 Trans-Infection Mediated by DCs: The Tip of the Iceberg of Cell-to-Cell Viral Transmission.
Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.
Dissemination of Mycobacterium tuberculosis is associated to a SIGLEC1 null variant that limits antigen exchange via trafficking extracellular vesicles